Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Senti Biosciences (SNTI) Return on Capital Employed (2021 - 2025)

Senti Biosciences has reported Return on Capital Employed over the past 5 years, most recently at 1.81% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 1.81% for Q4 2025, down 87.0% from a year ago — trailing twelve months through Dec 2025 was 1.81% (down 87.0% YoY), and the annual figure for FY2025 was 1.14%, down 50.0%.
  • Return on Capital Employed for Q4 2025 was 1.81% at Senti Biosciences, down from 1.36% in the prior quarter.
  • Over the last five years, Return on Capital Employed for SNTI hit a ceiling of 0.16% in Q4 2021 and a floor of 1.81% in Q4 2025.
  • Median Return on Capital Employed over the past 5 years was 0.77% (2025), compared with a mean of 0.74%.
  • Peak annual rise in Return on Capital Employed hit 16bps in 2025, while the deepest fall reached -87bps in 2025.
  • Senti Biosciences' Return on Capital Employed stood at 0.16% in 2021, then tumbled by -140bps to 0.39% in 2022, then tumbled by -111bps to 0.82% in 2023, then fell by -15bps to 0.94% in 2024, then tumbled by -92bps to 1.81% in 2025.
  • The last three reported values for Return on Capital Employed were 1.81% (Q4 2025), 1.36% (Q3 2025), and 0.98% (Q2 2025) per Business Quant data.